Views & Analysis Sponsored Media means business COVID-19 has left us more reliant on media than ever – both the pharma industry and society as a whole.
Views & Analysis Emotional empathy is driving brand equity How the COVID-19 pandemic is forging pharmaceutical brands into better shape.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
